| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2979128 | The Journal of Thoracic and Cardiovascular Surgery | 2015 | 9 Pages |
Abstract
Intraoperative molecular imaging with a targeted contrast agent can identify lung adenocarcinomas, and this technology is currently useful in patients with subpleural tumors, irrespective of size. With further refinements, this tool may prove useful in locating adenocarcinomas that are deeper in the lung parenchyma, in lymph nodes, and at pleural and resection margins.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Olugbenga T. MD, Elizabeth M. BA, Jack X. BS, Ryan P. BA, Ollin G. BA, Charuhas G. MD, Daniel F. PhD, Shuming PhD, Philip S. PhD, Sunil MD,